Medacta Group (MEDGF) Short Interest Ratio & Short Volume $83.91 0.00 (0.00%) (As of 05/13/2024) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Medacta Group Short Interest DataMedacta Group (MEDGF) has a short interest of 13,400 shares. This marks a -10.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 200 shares to cover all short positions.Current Short Interest13,400 sharesPrevious Short Interest15,000 sharesChange Vs. Previous Month-10.67%Dollar Volume Sold Short$1.12 millionShort Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume11 sharesAverage Trading Volume200 sharesToday's Volume Vs. Average6% Short Selling Medacta Group? Sign up to receive the latest short interest report for Medacta Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDGF Short Interest Over TimeMEDGF Days to Cover Over TimeMEDGF Percentage of Float Shorted Over Time Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Medacta Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202413,400 shares $1.12 million -10.7%N/A0 $83.91 9/30/202415,000 shares $1.26 million -1.3%N/A0 $83.91 9/15/202415,200 shares $1.28 million -0.7%N/A0 $83.91 8/31/202415,300 shares $1.28 million -6.7%N/A0 $83.91 8/15/202416,400 shares $1.38 million +1.2%N/A0 $83.91 7/31/202416,200 shares $1.36 million -2.4%N/A0 $83.91 Get the Latest News and Ratings for MEDGF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medacta Group and its competitors with MarketBeat's FREE daily newsletter. 7/15/202416,600 shares $1.39 million -9.8%N/A0 $83.91 6/30/202418,400 shares $1.54 million +4.6%N/A0 $83.91 6/15/202417,600 shares $1.48 million -2.8%N/A0 $83.91 5/31/202418,100 shares $1.52 million +11.0%N/A0 $83.91 5/15/202416,300 shares $1.37 million -23.5%N/A163 $83.91 4/30/202421,300 shares $1.79 million +88.5%N/A0 $83.91 4/15/202411,300 shares $948,183.00 +29.9%N/A0 $83.91 3/31/20248,700 shares $730,017.00 +4.8%N/A0 $83.91 3/15/20248,300 shares $696,453.00 No ChangeN/A0 $83.91 2/29/20248,300 shares $696,453.00 -56.8%N/A0 $83.91 2/15/202419,200 shares $1.61 million No ChangeN/A0 $83.91 1/15/202420,500 shares $1.72 million +2.5%N/A0 $83.91 12/31/202320,000 shares $1.68 million -5.7%N/A0 $83.91 12/15/202321,200 shares $1.78 million +72.4%N/A0 $83.91 11/30/202312,300 shares $1.03 million -3.9%N/A0 $83.91 11/15/202312,800 shares $1.07 million +6.7%N/A0 $83.91 10/31/202312,000 shares $1.01 million -35.8%N/A0 $83.91 10/15/202318,700 shares $1.57 million +33.6%N/A0 $83.91 9/30/202314,000 shares $1.17 million +21.7%N/A0 $83.91 9/15/202311,500 shares $964,965.00 -5.0%N/A0 $83.91 8/31/202312,100 shares $1.02 million +2.5%N/A0 $83.91 8/15/202311,800 shares $990,138.00 -5.6%N/A0 $83.91 7/31/202312,500 shares $1.05 million +9.7%N/A0 $83.91 7/15/202311,400 shares $956,574.00 -10.2%N/A0 $83.91 6/30/202312,700 shares $1.07 million -18.6%N/A0 $83.91 6/15/202315,600 shares $1.31 million +4.0%N/A0 $83.91 5/31/202315,000 shares $1.26 million -5.1%N/A0 $83.91 5/15/202315,800 shares $1.33 million +30.6%N/A0 $83.91 4/30/202312,100 shares $1.02 million -4.7%N/A0 $83.91 4/15/202312,700 shares $1.07 million -16.5%N/A0 $83.91 3/31/202315,200 shares $1.28 million +18.8%N/A0 $83.91 3/15/202312,800 shares $1.07 million -0.8%N/A128 $83.91 2/28/202312,900 shares $1.08 million -5.8%N/A0 $83.91 2/15/202313,700 shares $1.15 million -2.1%N/A0 $83.91Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 1/31/202314,000 shares $1.17 million -2.8%N/A0 $83.91 1/15/202314,400 shares $1.21 million -3.4%N/A0 $83.91 12/30/202214,900 shares $1.25 million -1.3%N/A0 $83.91 12/15/202215,100 shares $1.27 million -9.0%N/A151 $83.91 11/30/202216,600 shares $1.39 million +1.8%N/A0 $83.91 11/15/202216,300 shares $1.37 million +3.8%N/A163 $83.91 10/31/202215,700 shares $1.32 million -11.3%N/A0 $83.91 10/15/202217,700 shares $1.49 million +12.0%N/A0 $83.91 9/30/202215,800 shares $1.33 million +690.0%N/A158 $83.91 9/15/20222,000 shares $172,655.00 -44.4%N/A20 $86.33 8/31/20223,600 shares $309,600.00 -5.3%N/A0 $86.00 8/15/20223,800 shares $326,800.00 +81.0%N/A0 $86.00 7/31/20222,100 shares $180,600.00 -44.7%N/A21 $86.00 7/15/20223,800 shares $326,800.00 +31.0%N/A38 $86.00 6/30/20222,900 shares $359,600.00 No ChangeN/A0 $124.00 6/15/20222,900 shares $359,600.00 -56.1%N/A0 $124.00 5/31/20226,600 shares $818,400.00 +73.7%N/A0 $124.00 5/15/20223,800 shares $471,200.00 -44.1%N/A0 $124.00 4/30/20226,800 shares $843,200.00 +1.5%N/A0 $124.00 4/15/20226,700 shares $830,800.00 +48.9%N/A0 $124.00 3/31/20224,500 shares $558,000.00 -73.5%N/A0 $124.00 3/15/202217,000 shares $2.11 million +6.9%N/A170 $124.00 2/28/202215,900 shares $2.27 million +9.7%N/A0 $143.00 2/15/202214,500 shares $2.07 million +400.0%N/A0 $143.00 1/31/20222,900 shares $414,700.00 +480.0%N/A29 $143.00 1/15/2022500 shares $0.00 No ChangeN/A5 $0.00 12/31/2021500 shares $71,500.00 -16.7%N/A5 $143.00 12/15/2021600 shares $85,800.00 +500.0%N/A0 $143.00 11/30/2021100 shares $14,300.00 -93.3%N/A1 $143.00 11/15/20211,500 shares $185,250.00 +36.4%N/A0 $123.50 10/29/20211,100 shares $135,850.00 -45.0%N/A11 $123.50 10/15/20212,000 shares $247,000.00 +100.0%N/A0 $123.50 9/30/20211,000 shares $123,500.00 +25.0%N/A0 $123.50 9/15/2021800 shares $98,800.00 -20.0%N/A0 $123.50 8/31/20211,000 shares $123,500.00 +100.0%N/A0 $123.50 8/13/2021500 shares $61,750.00 -16.7%N/A0 $123.50 7/30/2021600 shares $74,100.00 +50.0%N/A0 $123.50 7/15/2021400 shares $49,400.00 No ChangeN/A0 $123.50 6/30/2021400 shares $49,400.00 -81.0%N/A4 $123.50 6/15/20212,100 shares $259,350.00 +23.5%N/A21 $123.50 5/28/20211,700 shares $0.00 +240.0%N/A17 $0.00 MEDGF Short Interest - Frequently Asked Questions What is Medacta Group's current short interest? Short interest is the volume of Medacta Group shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 13,400 shares of MEDGF short. Learn More on Medacta Group's current short interest. Is Medacta Group's short interest increasing or decreasing? Medacta Group saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 13,400 shares, a decrease of 10.7% from the previous total of 15,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Medacta Group stock? Short selling MEDGF is an investing strategy that aims to generate trading profit from Medacta Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medacta Group? A short squeeze for Medacta Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDGF, which in turn drives the price of the stock up even further. How often is Medacta Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDGF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies BICO Group AB (publ) Short Squeeze Bone Biologics Short Squeeze Caliber Imaging & Diagnostics Short Squeeze CellaVision AB (publ) Short Squeeze Cochlear Short Squeeze Demant A/S Short Squeeze DIH Holding US Short Squeeze Drägerwerk AG & Co. KGaA Short Squeeze Electromedical Technologies Short Squeeze Embla Medical hf. Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDGF) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medacta Group SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Medacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDGF Stock Alerts